NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 289 filers reported holding NATERA INC in Q1 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,433,700 | -9.1% | 32,400 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $1,576,584 | +491.6% | 32,400 | +575.0% | 0.00% | +300.0% |
| Q1 2023 | $266,496 | -88.1% | 4,800 | -91.4% | 0.00% | -85.7% |
| Q4 2022 | $2,240,241 | -73.5% | 55,769 | -71.1% | 0.01% | -75.9% |
| Q3 2022 | $8,448,000 | -42.2% | 192,785 | -53.2% | 0.03% | -39.6% |
| Q2 2022 | $14,609,000 | -74.0% | 412,227 | -70.2% | 0.05% | -71.1% |
| Q1 2022 | $56,288,000 | +1656.8% | 1,383,682 | +3933.6% | 0.17% | +2271.4% |
| Q4 2021 | $3,204,000 | -89.0% | 34,304 | -86.6% | 0.01% | -89.4% |
| Q2 2021 | $29,101,000 | -52.8% | 256,325 | -57.8% | 0.07% | -59.0% |
| Q1 2021 | $61,693,000 | +84.3% | 607,574 | +80.7% | 0.16% | +67.7% |
| Q4 2020 | $33,470,000 | +192.2% | 336,310 | +112.1% | 0.10% | +134.1% |
| Q3 2020 | $11,456,000 | +16.6% | 158,582 | -19.5% | 0.04% | -16.3% |
| Q2 2020 | $9,825,000 | -2.4% | 197,050 | -41.5% | 0.05% | -40.2% |
| Q1 2020 | $10,063,000 | -30.6% | 337,015 | -21.7% | 0.08% | +86.4% |
| Q4 2019 | $14,508,000 | +1451.7% | 430,619 | +1411.2% | 0.04% | +1366.7% |
| Q3 2019 | $935,000 | -61.5% | 28,495 | -67.6% | 0.00% | -62.5% |
| Q2 2019 | $2,426,000 | -71.7% | 87,947 | -78.8% | 0.01% | -71.4% |
| Q1 2019 | $8,568,000 | +17.5% | 415,531 | -20.5% | 0.03% | -3.4% |
| Q4 2018 | $7,293,000 | -33.0% | 522,454 | +14.9% | 0.03% | -3.3% |
| Q3 2018 | $10,885,000 | +157.8% | 454,694 | +102.7% | 0.03% | +130.8% |
| Q2 2018 | $4,223,000 | +648.8% | 224,365 | +412.6% | 0.01% | +550.0% |
| Q3 2017 | $564,000 | – | 43,771 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
| Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
| Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
| Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
| Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
| BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
| Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
| Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
| SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |